These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8195580)

  • 21. [Possible combination of clozapine and specific serotonin reuptake inhibitors?].
    Caroli F; Aymard N; Viala A; Smagghe PO
    Encephale; 1995; 21(6):482-3. PubMed ID: 8674476
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients.
    Austin LS; Arana GW; Melvin JA
    J Clin Psychiatry; 1990 Aug; 51(8):344-5. PubMed ID: 2380160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undue mood elevation in unipolar patients following cessation of lithium augmentation treatment: implications for the understanding of mood disorders.
    Hoaken PC; Hoaken P
    Can J Psychiatry; 1996 Feb; 41(1):46-8. PubMed ID: 8919423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Erythrocyte/plasma ratio of lithium. Determination method and individual stability].
    Barthelmebs M; Ehrhardt JD; Schweitzer-Ehret A; Danion JM; Imbs JL
    Encephale; 1993; 19(4):321-7. PubMed ID: 8275919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prozac: pros and cons.
    Glod C
    J Psychosoc Nurs Ment Health Serv; 1990 Dec; 28(12):33-4. PubMed ID: 2283599
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disabling parkinsonism due to lithium: a case report.
    Holroyd S; Smith D
    J Geriatr Psychiatry Neurol; 1995 Apr; 8(2):118-9. PubMed ID: 7794475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine-TCA interaction.
    March JS; Moon RL; Johnston H
    J Am Acad Child Adolesc Psychiatry; 1990 Nov; 29(6):985-6. PubMed ID: 2273036
    [No Abstract]   [Full Text] [Related]  

  • 29. Lithium or desipramine augmentation of fluoxetine treatment.
    Nelson JC; Price LH
    Am J Psychiatry; 1995 Oct; 152(10):1538-9. PubMed ID: 7573606
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluoxetine responsivity mediated by serum levels, not dose.
    Schwartz EM; Markovitz PJ
    J Clin Psychopharmacol; 1993 Oct; 13(5):363-4. PubMed ID: 8227496
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse effects of switching from fluoxetine to desipramine.
    Van Ameringen M; Mancini C
    Can J Psychiatry; 1992 May; 37(4):278. PubMed ID: 1611591
    [No Abstract]   [Full Text] [Related]  

  • 32. Maintenance treatment for recurrent depression in late life. A four-year outcome study.
    Flint AJ; Rifat SL
    Am J Geriatr Psychiatry; 2000; 8(2):112-6. PubMed ID: 10804071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 24-month follow-up study of unipolar subjects: a comparison between lithium and fluvoxamine.
    Franchini L; Gasperini M; Smeraldi E
    J Affect Disord; 1994 Dec; 32(4):225-31. PubMed ID: 7897085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy.
    Gigli GL; Diomedi M; Troisi A; Baldinetti F; Marciani MG; Girolami E; Pasini A
    Seizure; 1994 Sep; 3(3):221-4. PubMed ID: 8000717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
    Ivković M; Damjanović A; Jovanović A; Cvetić T; Jasović-Gasić M
    Psychiatr Danub; 2009 Jun; 21(2):187-93. PubMed ID: 19556947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.
    Browne M; Horn E; Jones TT
    Can J Psychiatry; 1993 May; 38(4):242-3. PubMed ID: 8518974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetine.
    Fava M; Rosenbaum JF; Cohen L; Reiter S; McCarthy M; Steingard R; Clancy K
    J Affect Disord; 1992 Aug; 25(4):229-34. PubMed ID: 1430659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible synergism between fluoxetine and lithium in refractory depression.
    Pope HG; McElroy SL; Nixon RA
    Am J Psychiatry; 1988 Oct; 145(10):1292-4. PubMed ID: 3262313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are the renal effects of lithium modified by frequency of administration?
    Abraham G; Waldron JJ; Lawson JS
    Acta Psychiatr Scand; 1995 Aug; 92(2):115-8. PubMed ID: 7572256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium treatment: a comparison of once- and twice-daily dosing.
    Abraham G; Delva N; Waldron J; Lawson JS; Owen J
    Acta Psychiatr Scand; 1992 Jan; 85(1):65-9. PubMed ID: 1546552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.